Cybin Unveils Data Suggesting Its Novel Psilocybin Analog Is the ‘Superior Molecule’
Business
Pre-clinical studies demonstrated multiple advantages, including less patient variability, faster onset of action, shorter duration of effect, and improved brain penetration.
Leave a Reply
Want to join the discussion?Feel free to contribute!